NEW YORK (GenomeWeb) – Israeli ag-bio firm NRGene has signed a deal with Illumina to co-market its proprietary de novo assembly informatics technology DeNovoMAGIC with Illumina's sequencers, the company announced today.

Illumina's sequencing technology is the fastest and most practical way to assemble complex genomes such as those of most crop and livestock species, NRGene said in a statement. In fact, the company has assembled various lines of wheat, maize, soy, forestry and fruit trees, and fish, among other organisms, the statement added.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.